Healthcare provider profile · identity verified

Maryrita K Mallet, MD

Psychiatry · WEATHERFORD, TX · NPI 1366478182

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Fluoxetine Hcl	Fluoxetine Hcl	593	55
Trazodone Hcl	Trazodone Hcl	495	51
Risperidone	Risperidone	442	40
Hydroxyzine Hcl	Hydroxyzine Hcl	391	34
Aripiprazole	Aripiprazole	382	36
Quetiapine Fumarate	Quetiapine Fumarate	332	26
Clonazepam	Clonazepam	304	32
Sertraline Hcl	Sertraline Hcl	297	32
Divalproex Sodium Er	Divalproex Sodium	286	30
Olanzapine	Olanzapine	274	18
Lorazepam	Lorazepam	247	38
Venlafaxine Hcl Er	Venlafaxine Hcl	236	25
Ziprasidone Hcl	Ziprasidone Hcl	230	17
Invega Sustenna	Paliperidone Palmitate	210	17
Gabapentin	Gabapentin	203	23
Paliperidone Er	Paliperidone	198	18
Divalproex Sodium	Divalproex Sodium	185	18
Lybalvi	Olanzapine/Samidorphan Malate	184	18
Bupropion Xl	Bupropion Hcl	180	20
Buspirone Hcl	Buspirone Hcl	179	19
Nuedexta	Dextromethorphan Hbr/Quinidine	174	20
Oxcarbazepine	Oxcarbazepine	165	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	164	20
Topiramate	Topiramate	164	19
Escitalopram Oxalate	Escitalopram Oxalate	139	14
Levetiracetam	Levetiracetam	135	14
Duloxetine Hcl	Duloxetine Hcl	130	suppressed
Clonidine Hcl	Clonidine Hcl	124	15
Lurasidone Hcl	Lurasidone Hcl	122	12
Memantine Hcl	Memantine Hcl	112	14
Bupropion Hcl Sr	Bupropion Hcl	111	suppressed
Carbamazepine Er	Carbamazepine	110	13
Atomoxetine Hcl	Atomoxetine Hcl	108	11
Paroxetine Hcl	Paroxetine Hcl	106	suppressed
Propranolol Hcl	Propranolol Hcl	106	14
Citalopram Hbr	Citalopram Hydrobromide	105	13
Austedo	Deutetrabenazine	103	12
Alprazolam	Alprazolam	90	12
Lamotrigine	Lamotrigine	90	12
Haloperidol	Haloperidol	85	11
Levothyroxine Sodium	Levothyroxine Sodium	84	suppressed
Mirtazapine	Mirtazapine	72	suppressed
Clozapine	Clozapine	64	suppressed
Benztropine Mesylate	Benztropine Mesylate	58	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	56	suppressed
Prazosin Hcl	Prazosin Hcl	55	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	54	suppressed
Aristada	Aripiprazole Lauroxil	51	suppressed
Carbamazepine	Carbamazepine	50	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	50	suppressed
Amantadine	Amantadine Hcl	47	suppressed
Lithium Carbonate	Lithium Carbonate	43	suppressed
Guanfacine Hcl	Guanfacine Hcl	41	suppressed
Invega Trinza	Paliperidone Palmitate	39	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	32	suppressed
Naltrexone Hcl	Naltrexone Hcl	32	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Doxepin Hcl	Doxepin Hcl	28	suppressed
Liothyronine Sodium	Liothyronine Sodium	28	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Temazepam	Temazepam	27	suppressed
Abilify Maintena	Aripiprazole	25	suppressed
Imipramine Hcl	Imipramine Hcl	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Austedo Xr	Deutetrabenazine	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Risperidone Odt	Risperidone	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Glycopyrrolate	Glycopyrrolate	14	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Folic Acid	Folic Acid	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	12	suppressed
Diazepam	Diazepam	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error